Qing-Xin-Jie-Yu granule prevents myocardial infarction-induced apoptosis via inhibition of p38 MAPK pathway.

Researchers investigated whether a traditional Chinese herbal formula called Qing-Xin-Jie-Yu Granule (QXJYG) could protect heart tissue after a heart attack. Heart attacks occur when blood flow to the heart is blocked, causing cell death and permanent damage. The study used both laboratory mice with induced heart attacks and heart cells grown in low-oxygen conditions to mimic what happens during a heart attack.

The researchers found that QXJYG provided significant protection to the heart through multiple mechanisms. Mice treated with the herbal formula showed improved heart function and increased blood vessel formation in damaged tissue. The treatment reduced harmful oxidative stress markers while increasing protective antioxidant levels in the blood. Most importantly, QXJYG dramatically reduced cell death (apoptosis) in heart tissue by regulating a specific cellular pathway called p38 MAPK, which controls stress responses and inflammation.

The laboratory experiments confirmed these findings, showing that QXJYG reduced cell death and oxidative damage in heart cells deprived of oxygen. When combined with a pharmaceutical inhibitor of the same pathway, the herbal formula showed even greater protective effects, suggesting the two approaches work synergistically.

For patients, this research provides scientific evidence that traditional Chinese herbal medicine may offer meaningful protection after heart attacks by reducing tissue damage, supporting blood vessel growth, and preventing excessive cell death. While this study was conducted in animals and cells rather than human patients, it demonstrates promising mechanisms through which TCM formulas might complement conventional cardiac care. Patients interested in incorporating Chinese herbal medicine into their cardiac recovery should consult with a qualified, licensed acupuncturist or Chinese medicine practitioner experienced in cardiovascular conditions.

This study examined the cardioprotective mechanisms of Qing-Xin-Jie-Yu Granule (QXJYG) in myocardial infarction using network pharmacology, in vivo mouse models (left anterior descending coronary artery ligation), and in vitro hypoxic H9C2 cardiomyocytes. QXJYG administration significantly improved cardiac function via echocardiography, increased microvascular density (CD31 immunohistochemistry), and reduced myocardial apoptosis (TUNEL staining). Biochemical analysis revealed decreased serum LDH and MDA with elevated SOD levels. Western blot analysis demonstrated QXJYG suppressed the p-p38 MAPK/p38 MAPK ratio, downregulated pro-apoptotic Bax, and upregulated anti-apoptotic Bcl-2 expression both in vivo and in vitro. Combination treatment with p38 MAPK inhibitor SB203580 enhanced QXJYG's anti-apoptotic effects, confirming pathway specificity. Network pharmacology and KEGG analysis identified oxidative stress and apoptosis pathways as primary targets. Clinical implications suggest QXJYG's multi-targeted approach addresses MI pathophysiology through p38 MAPK pathway inhibition, offering potential adjunctive therapy for acute coronary syndrome management in integrative cardiology protocols.